Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 6Recruiting 2Withdrawn 1Terminated 1Suspended 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 3Stomach Neoplasms 2Rectal Neuroendocrine Tumors 1Hemorrhage 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

tislelizumab 7Paclitaxel 5Radiotherapy 4Carboplatin 4Oxaliplatin 3Immune Checkpoint Inhibitors 3nedaplatin 2Radiation 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cisplatin 2Albumin-Bound Paclitaxel 2tranilast 1toripalimab 1sintilimab 1irinotecan sucrosofate 1camrelizumab 1apatinib 1anlotinib 1Surgical Procedures, Operative 1Specimen Handling 1Simvastatin 1S 1 (combination) 1Robotic Surgical Procedures 1Radiosurgery 1Pemetrexed 1Patient Reported Outcome Measures 1Observation 1Nutrition Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Esophageal Neoplasms × Endoscopic Mucosal Resection × Clear all
NCT06979986 2025-05-20

SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma

Fujian Cancer Hospital

Phase NA Not yet recruiting
102 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡